These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8911119)

  • 21. Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.
    Perry RR; Kang Y; Greaves BR
    Br J Cancer; 1995 Dec; 72(6):1441-6. PubMed ID: 8519657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells.
    Yee JA; Yan L; Dominguez JC; Allan EH; Martin TJ
    J Cell Physiol; 1993 Dec; 157(3):528-34. PubMed ID: 8253864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiestrogenic activity of DP-TAT-59, an active metabolite of TAT-59 against human breast cancer.
    Toko T; Shibata J; Nukatsuka M; Yamada Y
    Cancer Chemother Pharmacol; 1997; 39(5):390-8. PubMed ID: 9054952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity.
    Flaumenhaft R; Abe M; Mignatti P; Rifkin DB
    J Cell Biol; 1992 Aug; 118(4):901-9. PubMed ID: 1380001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.
    Butta A; MacLennan K; Flanders KC; Sacks NP; Smith I; McKinna A; Dowsett M; Wakefield LM; Sporn MB; Baum M
    Cancer Res; 1992 Aug; 52(15):4261-4. PubMed ID: 1322240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
    Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
    Ghahary A; Tredget EE; Mi L; Yang L
    Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of transforming growth factor-alpha by tamoxifen in human breast cancer.
    Noguchi S; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1993 Jul; 72(1):131-6. PubMed ID: 8508397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and regulation of the latent transforming growth factor-beta complex secreted by vascular pericytes.
    Marra F; Bonewald LF; Park-Snyder S; Park IS; Woodruff KA; Abboud HE
    J Cell Physiol; 1996 Mar; 166(3):537-46. PubMed ID: 8600157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of estrogen receptor DNA binding in untreated and acquired antiestrogen-resistant human breast tumors.
    Johnston SR; Lu B; Dowsett M; Liang X; Kaufmann M; Scott GK; Osborne CK; Benz CC
    Cancer Res; 1997 Sep; 57(17):3723-7. PubMed ID: 9288779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
    Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP
    Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of TGF-beta by an antiprogestin in the human breast cancer cell line T-47D.
    Dannecker C; Possinger K; Classen S
    Ann Oncol; 1996 Apr; 7(4):391-5. PubMed ID: 8805931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoid regulation of transforming growth factor-beta activation in urogenital sinus mesenchymal cells.
    Rowley DR
    Endocrinology; 1992 Jul; 131(1):471-8. PubMed ID: 1612028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-beta 1 (TGF-B1) liberation from its latent complex during embryo implantation and its regulation by estradiol in mouse.
    Maurya VK; Jha RK; Kumar V; Joshi A; Chadchan S; Mohan JJ; Laloraya M
    Biol Reprod; 2013 Oct; 89(4):84. PubMed ID: 23926286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiostatic role of astrocytes: suppression of vascular endothelial cell growth by TGF-beta and other inhibitory factor(s).
    Behzadian MA; Wang XL; Jiang B; Caldwell RB
    Glia; 1995 Dec; 15(4):480-90. PubMed ID: 8926041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor-beta production in anti-glomerular basement membrane disease in the rabbit.
    Coimbra T; Wiggins R; Noh JW; Merritt S; Phan SH
    Am J Pathol; 1991 Jan; 138(1):223-34. PubMed ID: 1987768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiotherapy-related lung fibrosis enhanced by tamoxifen.
    Bentzen SM; Skoczylas JZ; Overgaard M; Overgaard J
    J Natl Cancer Inst; 1996 Jul; 88(13):918-22. PubMed ID: 8656444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards a molecular basis for tamoxifen resistance in breast cancer.
    Johnston SR; Dowsett M; Smith IE
    Ann Oncol; 1992 Jul; 3(7):503-11. PubMed ID: 1498070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.